Table 1 Demographic and clinical characteristics of the study population and craniofacial pain types.
From: Fourteen year retrospective study of craniofacial pain in a neurological emergency department
Group, n (%a) | Total, 156 | TN, 122 (78.2) | TNp, 11 (7.1) | pON, 10 (6.4) | pPIFP, 4 (2.6) | GN, 4 (2.6) | NINp, 4 (2.6) | pTN+pGN, 1 (0.6) | |
|---|---|---|---|---|---|---|---|---|---|
Age at presentation (y) median, IQR | 61, 43–73 | 61, 41–72 | 71, 58–75 | 64, 46–69 | 36, 33–42 | 61, 51–78 | 67, 59–78 | 86 | |
Age at onset (y) median, IQR | 56, 40–69 | 56, 38–68 | 66, 51–75 | 65, 46–69 | 36, 33–42 | 58, 51–75 | 67, 59–78 | 86 | |
Sex | Female | 108 (69.2) | 84 (68.9) | 5 (45.5) | 8 (80.0) | 4 (100.0) | 3 (75.0) | 3 (75.0) | 1 (100.0) |
Duration | < 1 week | 26 (16.7) | 16 (13.1) | 2 (18.2) | 4 (40.0) | 2 (50.0) | 0 | 1 (25.0) | 1 (100.0) |
1 week – 3 months | 36 (23.1) | 20 (16.4) | 5 (45.5) | 3 (30.0) | 2 (50.0) | 3 (75.0) | 3 (75.0) | 0 | |
3 months – 1 year | 18 (11.5) | 17 (13.9) | 1 (9.1) | 0 | 0 | 0 | 0 | 0 | |
> 1 year | 68 (43.6) | 64 (52.5) | 2 (18.2) | 1 (10.0) | 0 | 1 (25.0) | 0 | 0 | |
Course | Monophasic - acute | 64 (41.0) | 37 (30.3) | 8 (72.7) | 7 (70.0) | 4 (100.0) | 3 (75.0) | 4 (100.0) | 1 (100.0) |
Relapsing - remitting | 68 (43.6) | 64 (52.5) | 1 (9.1) | 3 (30.0) | 0 | 0 | 0 | 0 | |
Chronic | 24 (15.4) | 21 (17.2) | 2 (18.2) | 0 | 0 | 1 (25.0) | 0 | 0 | |
Affected Side | Right | 93 (59.6) | 73 (59.8) | 6 (54.5) | 7 (70.0) | 2 (50.0) | 1 (25.0) | 3 (75.0) | 1 (100.0) |
Left | 56 (35.9) | 47 (38.5) | 3 (27.3) | 2 (20.0) | 1 (25.0) | 2 (50.0) | 1 (25.0) | 0 | |
Both | 5 (3.2) | 1 (0.8) | 2 (18.2) | 0 | 1 (25.0) | 1 (25.0) | 0 | 0 | |
Pain Intensity | Mild | 3 (1.9) | 3 (2.5) | 0 | 0 | 0 | 0 | 0 | 0 |
Moderate | 37 (23.7) | 25 (20.5) | 6 (54.5) | 2 (20.0) | 2 (50.0) | 2 (50.0) | 0 (0.0) | 0 | |
Severe | 70 (44.9) | 59 (48.4) | 3 (27.3) | 4 (40.0) | 1 (25.0) | 0 (0.0) | 2 (50.0) | 1 (100.0) | |
Trigger | Present | 83 (53.2) | 71 (58.2) | 2 (18.2) | 5 (50.0) | 2 (50.0) | 3 (75.0) | 0 | 0 |
CAS | Present | 22 (14.1) | 18 (14.8) | 2 (18.2) | 2 (20.0) | 0 | 0 | 0 | 0 |
SD | Present | 54 (34.6) | 41 (33.6) | 5 (45.5) | 4 (40.0) | 1 (25.0) | 1 (25.0) | 2 (50.0) | 0 |
Treated during visit | No therapy | 102 (65.4) | 80 (65.6) | 7 (63.6) | 5 (50.0) | 3 (75.0) | 4 (100.0) | 3 (75.0) | 0 |
Monoterapy | 34 (21.8) | 25 (20.5) | 3 (27.3) | 3 (30.0) | 1 (25.0) | 0 | 1 (25.0) | 1 (100.0) | |
Polytherapy | 20 (12.8) | 17 (13.9) | 1 (9.1) | 2 (20.0) | 0 | 0 | 0 | 0 | |
Therapy at discharge | No therapy | 4 (2.6) | 2 (1.6) | 1 (9.1) | 0 | 0 | 0 | 1 (25.0) | 0 |
Monoterapy | 59 (37.8) | 51 (41.8) | 1 (9.1) | 4 (40.0) | 0 | 2 (50.0) | 0 | 1 (100.0) | |
Polytherapy | 92 (59.0) | 68 (55.7) | 9 (81.8) | 6 (60.0) | 4 (100.0) | 2 (50.0) | 3 (75.0) | 0 | |
